Literature DB >> 33086918

Portal vein thrombosis, livedo reticularis, polymicrobial sepsis and high antiphospholipid antibody titers in a newborn: A clinicopathological conference of antiphospholipid-associated neonatal syndrome.

Himanshi Chaudhary1, Pooja Jindal1, Vignesh Pandiarajan1, Jogender Kumar1, Murugan Sudhakar1, Gopalakrishnan Ezhumalai1, Ritambhra Nada2, Kirti Gupta2.   

Abstract

Neonatal Antiphospholipid syndrome (APS) is a rare disease related to transplacental passage of antiphospholipid (aPL) antibodies from the mother or de novo production of aPL in a newborn. Neonatal aPL antibodies have rarely been associated with thrombosis. We describe a 5-week-old infant who developed fever, portal vein thrombosis and livedo reticularis like skin rash. Evaluation for thrombosis revealed high titers of antiphospholipid (aPL) antibodies (dual positive) in the child without any evidence of aPL antibodies in the mother, suggesting a de novo production in the child. Autopsy findings revealed umbilical vein sepsis with thrombosis of portal vein secondary to gram positive cocci which led to multiple liver and lung abscesses. Additionally, the baby had disseminated Cytomegalovirus (CMV) disease (acquired postnatally) involving walls of umbilical and portal vein, liver, lungs, adrenals, pancreas, thymus, and kidneys. Our case highlights the need for testing of aPL in every neonate with arterial or venous thrombosis even when the mother may have no features suggestive of an autoimmune disease.

Entities:  

Keywords:  Neonatal antiphospholipid syndrome; antiphospholipid antibody titers; autopsy; neonate; portal vein thrombosis

Year:  2020        PMID: 33086918     DOI: 10.1177/0961203320967418

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  1 in total

Review 1.  Suppurative Thrombosis of the Portal Vein (Pylephlebits): A Systematic Review of Literature.

Authors:  Dorde Jevtic; Tatjana Gavrancic; Ivana Pantic; Terri Nordin; Charles W Nordstrom; Marina Antic; Nikola Pantic; Marija Kaljevic; Bojan Joksimovic; Milan Jovanovic; Emilia Petcu; Mladen Jecmenica; Tamara Milovanovic; Lawrence Sprecher; Igor Dumic
Journal:  J Clin Med       Date:  2022-08-25       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.